{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:04:34Z","timestamp":1779897874790,"version":"3.53.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/ico.0b013e31828ffe0e","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:40:51Z","timestamp":1368182451000},"page":"e156-e160","source":"Crossref","is-referenced-by-count":15,"title":["Combination Effect of Antibiotics Against Bacteria Isolated From Keratitis Using Fractional Inhibitory Concentration Index"],"prefix":"10.1097","volume":"32","author":[{"given":"Takashi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210204","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":". Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.","volume":"87","author":"Bourcier","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R2-36-20210204","first-page":"961","article-title":"National surveillance of infectious keratitis in Japancurrent status of isolates, patient background, and treatment in Japanese.","volume":"11","year":"2006","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"R3-36-20210204","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.ophtha.2009.05.004","article-title":". Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management.","volume":"116","author":"Loh","year":"2009","journal-title":"Ophthalmology"},{"key":"R4-36-20210204","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12325-008-0107-x","article-title":"Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv Ther"},{"key":"R5-36-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.diagmicrobio.2006.04.017","article-title":". Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections.","volume":"56","author":"Iihara","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R7-36-20210204","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archophthalmol.2011.45","article-title":". Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.","volume":"129","author":"Fintelmann","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R8-36-20210204","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajo.2003.10.026","article-title":". Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R9-36-20210204","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1167\/iovs.09-4839","article-title":". An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.","volume":"51","author":"Sueke","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-36-20210204","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QCO.0b013e328017f878","article-title":"Infectious keratitis.","volume":"20","author":"Thomas","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R15-36-20210204","first-page":"409","article-title":"Srinivasan M, et al..","volume":"145","author":"Chen","year":"2008","journal-title":"Does in vitro susceptibility predict clinical outcome in bacterial keratitis Am J Ophthalmol"},{"key":"R16-36-20210204","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1167\/iovs.09-3933","article-title":". Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.","volume":"51","author":"Kaye","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-36-20210204","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/cid\/cis189","article-title":". Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.","volume":"54","author":"Lalitha","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R18-36-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0732-8893(98)00126-6","article-title":"In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.","volume":"33","author":"Isenberg","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R19-36-20210204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF01793856","article-title":"Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.","volume":"23","author":"Jenkins","year":"1995","journal-title":"Infection"},{"key":"R20-36-20210204","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/AAC.39.10.2220","article-title":". In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.","volume":"39","author":"Poulos","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-36-20210204","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dkg238","article-title":". In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.","volume":"51","author":"Dawis","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31828ffe0e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:35:24Z","timestamp":1621884924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201307000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31828ffe0e","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}